Presence of blocked needles in some ranibizumab (Lucentis®) injection administration packs (Lot numbers: S0043, S0047, S0049A, S0049)

Novartis Pharma would like to inform healthcare professionals that it has received complaints of the Becton-Dickinson (BD) Mircrolance 3 injection needles (contained within the Lucentis® injection administration pack) being blocked. There were 3 reports of bacterial endophthalmitis temporally associated with the occurrence of the blocked needles. The issue concerns the needle batch numbers 100224 and 100609 found within Lucentis® packs of lot numbers: S0043, S0047, S0049A, S0049. Healthcare professionals are advised not to use the needles provided in these lots of Lucentis® administration packs.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

17 May 2022

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.moh.gov.sg/hpp/, and follow the procedures below to access the MOH Alert system.

Step 1: On the top navigation ribbon of webpage, select 'For Healthcare Professionals' followed by 'Health Professionals Portal' and click on the choice of profession. User will be redirected to the specific HPP webpage for the selected profession.

Step 2: Click on the Restricted Content icon on the left panel of webpage and login via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’ section

Step 4: Click on the Drug Alert tab to view the DHCPLs.